Sort
25,944 grants matching “neurodegeneration”
Frontotemporal Dementias: Genotypes and Phenotypes
$2,194,207Virginia M Lee · University Of Pennsylvania · P01 · FY2020 · AG
Mitochondrial transport and energy metabolism in synaptic transmission and nerve degeneration and regeneration
$2,193,277Zu-Hang Sheng · National Institute Of Neurological Disorders And Stroke · ZIA · FY2019 · NS
Slow-wave activity as a modifier of the progression of neurodegeneration in Alzheimer's disease
$2,190,985Dmitry Gerashchenko · Harvard Medical School · RF1 · FY2019 · AG
SOUTH CAROLINA COBRE IN OXIDANTS, REDOX BALANCE AND STRESS SIGNALING
$2,188,590Kenneth D. Tew · Medical University Of South Carolina · P20 · FY2014 · GM
Imaging Pathophysiology in Aging and Neurodegeneration
$2,188,440William E Klunk · University Of Pittsburgh At Pittsburgh · P01 · FY2019 · AG
SOUTH CAROLINA COBRE IN OXIDANTS, REDOX BALANCE AND STRESS SIGNALING
$2,188,354Kenneth D. Tew · Medical University Of South Carolina · P20 · FY2015 · GM
The adaptive-innate immune interactome across multiple tissues in Alzheimer's disease
$2,188,178Panagiotis Roussos · Icahn School Of Medicine At Mount Sinai · R01 · FY2024 · AG
Regulation of mitochondrial DNA homeostasis and neuroinflammation by Fascin in Alzheimerâs Disease
$2,187,498Yongchao Charles Ma · Lurie Children'S Hospital Of Chicago · RF1 · FY2022 · AG
Defining the Effects of Astrocytic TDP-43 Dysregulation on Hippocampal Function
$2,186,307Anna Goldshmidt Orr · Weill Medical Coll Of Cornell Univ · RF1 · FY2020 · NS
Capturing the molecular complexity of tau pathology-associated proteomes involved in the etiology of Alzheimer's disease and related dementias
$2,183,377Wilfried Rossoll · Mayo Clinic Jacksonville · RF1 · FY2022 · AG
SOUTH CAROLINA COBRE IN OXIDANTS, REDOX BALANCE AND STRESS SIGNALING
$2,181,658Kenneth D. Tew · Medical University Of South Carolina · P20 · FY2012 · GM
Targeting MSUT2 with small molecules to ameliorate pathological tau
$2,181,250Brian C. Kraemer · Seattle Inst For Biomedical/Clinical Res · RF1 · FY2023 · AG
Mechanisms, response heterogeneity and dosing from MRI-derived electric field models in tDCS augmented cognitive training: a secondary data analysis of the ACT study
$2,180,958Adam J. Woods · University Of Florida · RF1 · FY2021 · AG
Autophagy, Inflammation and Metabolism (AIM) in Disease Center
$2,180,372Vojo P Deretic · University Of New Mexico Health Scis Ctr · P20 · FY2021 · GM
Presenilin Biology and the Mechanism of Alzheimer's Disease
$2,180,073Dennis J Selkoe · Brigham And Women'S Hospital · P01 · FY2009 · AG
Mentoring Vision Research in Oklahoma
$2,178,077University Of Oklahoma Hlth Sciences Ctr · P20 · FY2003 · RR
Autophagy, Inflammation and Metabolism (AIM) in Disease Center
$2,174,751Vojo P Deretic · University Of New Mexico Health Scis Ctr · P20 · FY2019 · GM
Interventional approaches for restoring vision
$2,174,286Anand Swaroop · National Eye Institute · ZIA · FY2015 · EY
Resilience to Alzheimer's disease by targeting adult hippocampal neurogenesis
$2,173,794Se Hoon Choi · Massachusetts General Hospital · RF1 · FY2024 · AG
COBRE GRANT
$2,171,415Jeffrey L. Cummings · Cleveland Clinic Foundation · P20 · FY2016 · GM
Shape-based personalized AT(N) imaging markers of Alzheimer's disease
$2,169,981Yonggang Shi · University Of Southern California · RF1 · FY2023 · AG
National Center for Drug Discovery in Neurodegeneration
$2,168,409Ross L Stein · Brigham And Women'S Hospital · U24 · FY2007 · NS
COBRE GRANT
$2,167,171Jeffrey L. Cummings · Cleveland Clinic Foundation · P20 · FY2015 · GM
Pro-inflammatory cytokine lowering anti-inflammatory drugs
$2,166,049Nigel H. Greig · National Institute On Aging · ZIA · FY2023 · AG
Alzheimer's disease drug development
$2,163,807Nigel H. Greig · National Institute On Aging · ZIA · FY2019 · AG